Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study Article

sustainable development goals

publication date

  • August 5, 2023

webpage

published in

start page

  • 392

end page

  • 399

volume

  • 189

issue

  • 4